Department of Mathematics, Imperial College London, London, United Kingdom.
Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands.
Elife. 2022 Aug 3;11:e76487. doi: 10.7554/eLife.76487.
More than 300 cities including the city of Amsterdam in the Netherlands have joined the UNAIDS Fast-Track Cities initiative, committing to accelerate their HIV response and end the AIDS epidemic in cities by 2030. To support this commitment, we aimed to estimate the number and proportion of Amsterdam HIV infections that originated within the city, from Amsterdam residents. We also aimed to estimate the proportion of recent HIV infections during the 5-year period 2014-2018 in Amsterdam that remained undiagnosed.
We located diagnosed HIV infections in Amsterdam using postcode data (PC4) at time of registration in the ATHENA observational HIV cohort, and used HIV sequence data to reconstruct phylogeographically distinct, partially observed Amsterdam transmission chains. Individual-level infection times were estimated from biomarker data, and used to date the phylogenetically observed transmission chains as well as to estimate undiagnosed proportions among recent infections. A Bayesian Negative Binomial branching process model was used to estimate the number, size, and growth of the unobserved Amsterdam transmission chains from the partially observed phylogenetic data.
Between 1 January 2014 and 1 May 2019, there were 846 HIV diagnoses in Amsterdam residents, of whom 516 (61%) were estimated to have been infected in 2014-2018. The rate of new Amsterdam diagnoses since 2014 (104 per 100,000) remained higher than the national rates excluding Amsterdam (24 per 100,000), and in this sense Amsterdam remained a HIV hotspot in the Netherlands. An estimated 14% [12-16%] of infections in Amsterdan MSM in 2014-2018 remained undiagnosed by 1 May 2019, and 41% [35-48%] in Amsterdam heterosexuals, with variation by region of birth. An estimated 67% [60-74%] of Amsterdam MSM infections in 2014-2018 had an Amsterdam resident as source, and 56% [41-70%] in Amsterdam heterosexuals, with heterogeneity by region of birth. Of the locally acquired infections, an estimated 43% [37-49%] were in foreign-born MSM, 41% [35-47%] in Dutch-born MSM, 10% [6-18%] in foreign-born heterosexuals, and 5% [2-9%] in Dutch-born heterosexuals. We estimate the majority of Amsterdam MSM infections in 2014-2018 originated in transmission chains that pre-existed by 2014.
This combined phylogenetic, epidemiologic, and modelling analysis in the UNAIDS Fast-Track City Amsterdam indicates that there remains considerable potential to prevent HIV infections among Amsterdam residents through city-level interventions. The burden of locally acquired infection remains concentrated in MSM, and both Dutch-born and foreign-born MSM would likely benefit most from intensified city-level interventions.
This study received funding as part of the H-TEAM initiative from Aidsfonds (project number P29701). The H-TEAM initiative is being supported by Aidsfonds (grant number: 2013169, P29701, P60803), Stichting Amsterdam Dinner Foundation, Bristol-Myers Squibb International Corp. (study number: AI424-541), Gilead Sciences Europe Ltd (grant number: PA-HIV-PREP-16-0024), Gilead Sciences (protocol numbers: CO-NL-276-4222, CO-US-276-1712, CO-NL-985-6195), and M.A.C AIDS Fund.
包括荷兰阿姆斯特丹市在内的 300 多个城市加入了艾滋病署快速通道城市倡议,承诺加快艾滋病毒应对速度,到 2030 年终结城市艾滋病疫情。为了支持这一承诺,我们旨在估计阿姆斯特丹 HIV 感染者中源自该市居民的人数和比例。我们还旨在估计 2014 年至 2018 年期间 5 年内阿姆斯特丹新感染 HIV 中仍未确诊的比例。
我们使用 ATHENA 观察性 HIV 队列登记时的邮政编码数据(PC4)定位阿姆斯特丹的诊断性 HIV 感染病例,并使用 HIV 序列数据重建具有地理差异的、部分观察到的阿姆斯特丹传播链。个体感染时间从生物标志物数据中估计,并用于对系统发育观察到的传播链进行日期标注,以及估计近期感染中未确诊的比例。贝叶斯负二项分支过程模型用于从部分观察到的系统发育数据中估计未观察到的阿姆斯特丹传播链的数量、大小和增长。
2014 年 1 月 1 日至 2019 年 5 月 1 日,阿姆斯特丹居民中有 846 例 HIV 诊断病例,其中 516 例(61%)估计是在 2014 年至 2018 年期间感染的。自 2014 年以来,阿姆斯特丹新诊断病例的发生率(每 10 万人中有 104 例)仍高于不包括阿姆斯特丹的全国水平(每 10 万人中有 24 例),从这个意义上说,阿姆斯特丹仍是荷兰的艾滋病毒热点地区。估计 2014 年至 2018 年期间阿姆斯特丹男男性行为者(MSM)中 14%[12-16%]的感染仍未在 2019 年 5 月 1 日之前确诊,阿姆斯特丹异性恋者中 41%[35-48%],出生地区不同,差异也不同。估计 2014 年至 2018 年期间阿姆斯特丹 MSM 感染中 67%[60-74%]的传染源是阿姆斯特丹居民,阿姆斯特丹异性恋者中 56%[41-70%],出生地区不同,差异也不同。在本地获得的感染中,估计有 43%[37-49%]是外国出生的 MSM,41%[35-47%]是荷兰出生的 MSM,10%[6-18%]是外国出生的异性恋者,5%[2-9%]是荷兰出生的异性恋者。我们估计 2014 年至 2018 年期间阿姆斯特丹 MSM 感染的大多数源自 2014 年之前存在的传播链。
UNAIDS 快速通道城市阿姆斯特丹的这项综合系统发育、流行病学和建模分析表明,通过城市层面的干预措施,仍有很大潜力预防阿姆斯特丹居民感染艾滋病毒。本地获得的感染负担仍然集中在 MSM 中,荷兰出生和外国出生的 MSM 都可能从加强城市层面的干预措施中受益最多。
本研究作为艾滋病署快速通道城市阿姆斯特丹倡议的一部分,得到了艾滋病基金的资助(项目编号 P29701)。H-TEAM 倡议得到了艾滋病基金(2013169、P29701、P60803 号赠款)、阿姆斯特丹晚宴基金会、百时美施贵宝国际公司(研究号 AI424-541)、吉利德科学欧洲有限公司(赠款号 PA-HIV-PREP-16-0024)、吉利德科学公司(协议号 CO-NL-276-4222、CO-US-276-1712、CO-NL-985-6195)和 M.A.C 艾滋病基金的支持。